Core Viewpoint - The company has announced a guarantee for its subsidiary, Wuhan Jianmin Pharmaceutical Group Weisheng Pharmaceutical Co., Ltd., to secure a bank credit line of 25 million yuan from Bank of Communications Hanyang Branch for operational needs [2][6]. Summary by Sections Guarantee Overview - The guaranteed amount is 25 million yuan with a one-year term, aimed at supporting the subsidiary's daily operational cash flow [2][6]. - The company will provide a joint liability guarantee for the credit line application, which includes various financial products such as working capital loans and bank acceptance bills [2][4]. Internal Decision-Making Process - The company's board approved the guarantee during the 33rd meeting of the 10th board on March 20, 2025, and it was subsequently ratified at the annual shareholders' meeting on April 15, 2025 [3][7]. - The company has a total guarantee limit of up to 100 million yuan for its subsidiaries, with no existing guarantees for Weisheng prior to this announcement [3][8]. Subsidiary Information - Weisheng is a wholly-owned subsidiary of the company, currently in good operational and credit standing, indicating a manageable risk for the guarantee [6][8]. Guarantee Agreement Details - The guarantee covers all principal and interest obligations under the main contract, including various financing costs [4][5]. - The guarantee period is calculated based on the repayment terms of the main debts, extending up to three years after the last due date [5]. Necessity and Reasonableness of the Guarantee - The guarantee is deemed necessary to support the subsidiary's operational funding needs, which will enhance its financing capabilities and alleviate liquidity pressure [6][8]. - The company has a history of providing guarantees for its subsidiaries without any overdue obligations [6][8]. Cumulative Guarantee Situation - As of the announcement date, the total guarantee amount provided by the company to its subsidiaries is 356 million yuan, representing 14.62% of the company's audited net assets of approximately 2.435 billion yuan [8]. - There are no overdue guarantees or obligations requiring the company to assume responsibility [8].
健民药业集团股份有限公司关于为子公司银行授信额度提供担保实施的公告